https://www.selleckchem.com/products/arry-382.html 05). CsA inhibited the expression of most genes associated with inflammatory response in NHDFs. There were only 19 genes with a fold change (FC) lower than -2.0, among which EGR1, FOS, PBK, CDK1 and TOP2A had the lowest expression, as did CXCL2 which can directly impact inflammation. Furthermore, ZNF451 was strongly induced, and COL1A1, COL3A1, IL33, TNFRSFs were weakly upregulated (FC lower than 2.0). CONCLUSION The CsA in therapeutic concentration influence the genes linked to inflammatory response (in the transcriptional level) in human dermal fibroblasts. The findings suggest that the potential mechanism of CsA action in this concentration and on these genes can be associated with a profibrotic and proapoptotic, and genotoxic effects. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.BACKGROUND Semaphorin 3F (SEMA3F) plays a substantial role in carcinogenesis, because of its role in inducing angiogenesis, and also creating a microenvironment for the developing tumor. OBJECTIVE The purpose of this work was to assess the impact of cisplatin depending on the concentration and exposure time on the expression pattern of SEMA3F in an endometrial cancer cell line. MATERIALS AND METHODS Cultures of the Ishikawa endometrial cancer cells were incubated with cisplatin with the following concentrations 2.5µM; 5µM; and 10µM and for the following periods of time 12; 24; and 48 hours. Cells not incubated with the drug constituted the control in the experiment. To determine the effect of cisplatin on the expression of SEMA3F the real-time quantitative reverse transcription reaction (RtqPCR; mRNA) was used, as well as the ELISA assay (protein). The statistical analysis was done with the admission of p less then 0.05. RESULTS The silencing of SEMA3F expression on the transcriptome and proteome levels in a culture unexposed to the effects of cisplatin in comparison to endometrial cance